title: Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
authors.forename: Francesco
authors.initials: F
authors.lastname: Drago
authors.forename: Carlo
authors.initials: C
authors.lastname: Brusati
authors.forename: Giovanni
authors.initials: G
authors.lastname: Desirello
authors.forename: Marco
authors.initials: M
authors.lastname: Cacciapuoti
authors.forename: Alfredo
authors.initials: A
authors.lastname: Rebora
mesh_terms: D000368:Aged; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*; D013450:Sulfones / Q000009:adverse effects*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib